Actively Recruiting
The Role of Laryngopharyngeal Reflux in IPF
Led by National Jewish Health · Updated on 2024-11-14
60
Participants Needed
1
Research Sites
434 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
CONDITIONS
Official Title
The Role of Laryngopharyngeal Reflux in IPF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of IPF
- Age 40 to 95 years
- Able to read, speak, and understand English
- If taking medication for reflux or GERD, must be on a stable dose for at least 4 weeks before consent
You will not qualify if you...
- Not meeting all inclusion criteria
- Pregnant females
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Jewish Health
Denver, Colorado, United States, 80206
Actively Recruiting
Research Team
M
Matthew Koslow, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here